These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11408232)

  • 1. Pharmacodynamic evaluation of RWJ-270201, a novel neuraminidase inhibitor, in a lethal murine model of influenza predicts efficacy for once-daily dosing.
    Drusano GL; Preston SL; Smee D; Bush K; Bailey K; Sidwell RW
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2115-8. PubMed ID: 11408232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
    Sidwell RW; Smee DF; Huffman JH; Barnard DL; Bailey KW; Morrey JD; Babu YS
    Antimicrob Agents Chemother; 2001 Mar; 45(3):749-57. PubMed ID: 11181355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
    Bantia S; Parker CD; Ananth SL; Horn LL; Andries K; Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin T; Hutchison TL; Montgomery JA; Kellog DL; Babu YS
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1162-7. PubMed ID: 11257030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201.
    Sidwell RW; Smee DF; Huffman JH; Barnard DL; Morrey JD; Bailey KW; Feng WC; Babu YS; Bush K
    Antiviral Res; 2001 Sep; 51(3):179-87. PubMed ID: 11448729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza.
    Young D; Fowler C; Bush K
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1905-13. PubMed ID: 11779391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model.
    Bantia S; Kellogg D; Parker CD; Babu YS
    Antiviral Res; 2010 Dec; 88(3):276-80. PubMed ID: 20943201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
    Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS
    Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-influenza virus activity of peramivir in mice with single intramuscular injection.
    Bantia S; Arnold CS; Parker CD; Upshaw R; Chand P
    Antiviral Res; 2006 Jan; 69(1):39-45. PubMed ID: 16325932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination treatment of influenza A virus infections in cell culture and in mice with the cyclopentane neuraminidase inhibitor RWJ-270201 and ribavirin.
    Smee DF; Bailey KW; Morrison AC; Sidwell RW
    Chemotherapy; 2002 May; 48(2):88-93. PubMed ID: 12011541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice.
    Sidwell RW; Smee DF; Bailey KW; Burger RA
    Int Immunopharmacol; 2001 Jun; 1(6):1211-8. PubMed ID: 11407315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection.
    Mishin VP; Hayden FG; Signorelli KL; Gubareva LV
    Antiviral Res; 2006 Aug; 71(1):64-8. PubMed ID: 16581141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population analysis of the pharmacokinetics and pharmacodynamics of RWJ-270201 (BCX-1812) in treating experimental influenza A and B virus in healthy volunteers.
    Iyer GR; Liao S; Massarella J
    AAPS PharmSci; 2002; 4(4):E22. PubMed ID: 12645994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812).
    Sidwell RW; Bailey KW; Morrey JD; Wong MH; Baldwin TJ; Smee DF
    Antiviral Res; 2003 Sep; 60(1):17-25. PubMed ID: 14516917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment.
    Barroso L; Treanor J; Gubareva L; Hayden FG
    Antivir Ther; 2005; 10(8):901-10. PubMed ID: 16430195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between in vivo antiviral activity and pharmacokinetic parameters of peramivir in influenza virus infection model in mice.
    Kodama M; Yoshida R; Hasegawa T; Izawa M; Kitano M; Baba K; Noshi T; Seki T; Okazaki K; Tsuji M; Kanazu T; Kamimori H; Homma T; Kobayashi M; Sakoda Y; Kida H; Sato A; Yamano Y
    Antiviral Res; 2014 Sep; 109():110-5. PubMed ID: 24997412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RWJ-270201 BioCryst Pharmaceuticals/Johnson & Johnson.
    Barnard DL
    Curr Opin Investig Drugs; 2000 Dec; 1(4):421-4. PubMed ID: 11249693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.
    Babu YS; Chand P; Bantia S; Kotian P; Dehghani A; El-Kattan Y; Lin TH; Hutchison TL; Elliott AJ; Parker CD; Ananth SL; Horn LL; Laver GW; Montgomery JA
    J Med Chem; 2000 Sep; 43(19):3482-6. PubMed ID: 11000002
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
    Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
    Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.
    Mancuso CE; Gabay MP; Steinke LM; Vanosdol SJ
    Ann Pharmacother; 2010; 44(7-8):1240-9. PubMed ID: 20516360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza].
    Reina J
    Rev Esp Quimioter; 2006 Dec; 19(4):317-22. PubMed ID: 17235399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.